Ewenstein, Bruce
CSL Behring,
United States
2024 Rank: 120830
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Immunology
Rank in SubField 1: 3767 out of 224060 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 120830 | 124323 |
| Total Cites | 6459 | 7463 |
| H-index | 46 | 50 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 113 | 116 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 544 | 603 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 2591 | 2915 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4944 | 5459 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.37 |
| Self-Citation Percentage |
13.45%
|
|
Ewenstein, Bruce
Takeda Development Center Americas, Inc.,
United States
2023 Rank: 114911
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Immunology
Rank in SubField 1: 3643 out of 210400 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 114911 | 117998 |
| Total Cites | 6132 | 7115 |
| H-index | 45 | 49 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 111 | 114 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 533 | 592 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 2478 | 2811 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4694 | 5197 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.37 |
| Self-Citation Percentage |
13.82%
|
|
Ewenstein, Bruce
Takeda Pharmaceutical Company Limited,
United States
2022 Rank: 105837
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Immunology
Rank in SubField 1: 3428 out of 199278 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105837 | 113178 |
| Total Cites | 5875 | 6847 |
| H-index | 46 | 48 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 109 | 112 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 519 | 578 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 2309 | 2627 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4393 | 4871 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
14.20%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.